PROGRAMMED CELL-DEATH (APOPTOSIS) IN IMMUNITY AND HEMATOLOGICAL NEOPLASIA

Citation
Pd. Allen et al., PROGRAMMED CELL-DEATH (APOPTOSIS) IN IMMUNITY AND HEMATOLOGICAL NEOPLASIA, British journal of biomedical science, 50(2), 1993, pp. 135-149
Citations number
120
Categorie Soggetti
Medical Laboratory Technology
ISSN journal
09674845
Volume
50
Issue
2
Year of publication
1993
Pages
135 - 149
Database
ISI
SICI code
0967-4845(1993)50:2<135:PC(IIA>2.0.ZU;2-U
Abstract
Programmed cell death, also commonly referred to as apoptosis, is a ge netically controlled sequence of events, often requiring protein synth esis, which results in cell death. Although initially described 20 yea rs ago, it is only recently that its role as a mechanism in controllin g cell population size and content has been fully realised. In this re view the biochemical events of apoptosis are discussed briefly, follow ed by a more detailed look at the role of programmed cell death in the control of haemopoiesis and the maintenance of a balanced functional immune system. The role of proto-oncogenes and suppressor genes known to regulate programmed cell death is covered, and also their influence on the induction and maintenance of neoplastic disease. Finally, the potential role of apoptosis in the resistance of haematological malign ancies to chemotherapy is commented on.